Selective enhancing effect of early mitotic inhibitor 1 (Emi1) depletion on the sensitivity of doxorubicin or x-ray treatment in human cancer cells

Journal of Biological Chemistry

Volumn 288, Issue 24, 2013, Pages 17238-17252

  Shimizu, Natsumi ^a,f   Nakajima, Nakako Izumi ^b   Tsunematsu, Takaaki ^a   Ogawa, Ikuko ^c   Kawai, Hidehiko ^d   Hirayama, Ryoichi ^b   Fujimori, Akira ^b   Yamada, Akiko ^e   Okayasu, Ryuichi ^b   Ishimaru, Naozumi ^e   Takata, Takashi ^a   Kudo, Yasusei ^a,e  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; ANTI-CANCER AGENTS; ANTI-CANCER REAGENT; CANCER CELL LINES; COMBINATION THERAPY; HUMAN CANCER CELLS; SYNERGISTIC EFFECT; UBIQUITIN LIGASES;

CELL CULTURE; CHEMOTHERAPY; DISEASES; PROTEINS; RADIOTHERAPY; TISSUE;

CELLS;

CELL PROTEIN; DOXORUBICIN; EARLY MITOTIC INHIBITOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; GLIOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN DEPLETION; THERAPY EFFECT; X IRRADIATION;

ANTICANCER DRUG; CANCER; CANCER THERAPY; CELL CYCLE; DNA DAMAGE; DNA SYNTHESIS; RADIATION BIOLOGY;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; F-BOX PROTEINS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; POLYPLOIDY; RADIATION TOLERANCE; RNA, SMALL INTERFERING;

EID: 84879053380     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.446351     Document Type: Article

References (50)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA-Cancer J. Clin. 61, 69-90
2. Takimoto, C. H., and Calvo, E. (2008) Principles of Oncologic Pharmacotherapy in Cancer Management: A Multidisciplinary Approach (Pazdur, R., Wagman, L. D., Camphausen, K. A., Hoskins W. J., eds) 11th Ed. pp. 1-9, Cmp United Business Media, Manhasset, NY
3. Pommier, Y., Leteurtre, F., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., and Kohn, K. W. (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12, 530-542 (Pubitemid 24312486)
4. Dancey, J. E., Bedard, P. L., Onetto, N., and Hudson, T. J. (2012) The genetic basis for cancer treatment decisions. Cell 148, 409-420
5. Reed, S. (2003) Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4, 855-864
6. Pagano, M., and Benmaamar, R. (2003) When protein destruction runs amok, malignancy is on the loose. Cancer Cell 4, 251-256 (Pubitemid 37329789)
7. Yamasaki, L., and Pagano, M. (2004) Cell cycle, proteolysis and cancer. Curr. Opin. Cell Biol. 16, 623-628 (Pubitemid 39463111)
8. Nakayama, K. I., and Nakayama, K. (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381
9. Peters, J. M. (2006) The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 7, 644-656
10. Cardozo, T., and Pagano, M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5, 739-751 (Pubitemid 39208183)
11. Hsu, J. Y., Reimann, J. D., Sørensen, C. S., Lukas, J., and Jackson, P. K. (2002) E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1. Nat. Cell Biol. 4, 358-366 (Pubitemid 34521031)
12. Reimann, J. D., Gardner, B. E., Margottin-Goguet, F., and Jackson, P. K. (2001) Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278-3285 (Pubitemid 34013499)
13. Reimann, J. D., Freed, E., Hsu, J. Y., Kramer, E. R., Peters, J. M., and Jackson, P. K. (2001) Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645-655 (Pubitemid 32524117)
14. βTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813-826
15. Guardavaccaro, D., Kudo, Y., Boulaire, J., Barchi, M., Busino, L., Donzelli, M., Margottin-Goguet, F., Jackson, P. K., Yamasaki, L., and Pagano, M. (2003) Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799-812 (Pubitemid 36676033)
16. Lehman, N. L., Tibshirani, R., Hsu, J. Y., Natkunam, Y., Harris, B. T., West, R. B., Masek, M. A., Montgomery, K., van de Rijn, M., and Jackson, P. K. (2007) Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 170, 1793-1805 (Pubitemid 47339321)
17. Gütgemann, I., Lehman, N. L., Jackson, P. K., and Longacre, T. A. (2008) Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Mod. Pathol. 21, 445-454 (Pubitemid 351441034)
18. Machida, Y. J., and Dutta, A. (2007) The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 21, 184-194 (Pubitemid 46155812)
19. Di Fiore, B., and Pines, J. (2007) Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C. J. Cell Biol. 177, 425-437 (Pubitemid 46718272)
20. Verschuren, E. W., Ban, K. H., Masek, M. A., Lehman, N. L., and Jackson, P. K. (2007) Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage- induced senescence. Mol. Cell. Biol. 27, 7955-7965 (Pubitemid 350086428)
21. Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., Hosokawa, H., and Nagayama, M. (2003) Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int. J. Oncol. 22, 891-898
22. Onozuka, H., Tsuchihara, K., and Esumi, H. (2011) Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs. Cancer Sci. 102, 975-982
23. Zhu, W., and Depamphilis, M. L. (2009) Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 69, 4870-4877
24. Mihaylov, I. S., Kondo, T., Jones, L., Ryzhikov, S., Tanaka, J., Zheng, J., Higa, L. A., Minamino, N., Cooley, L., and Zhang, H. (2002) Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol. Cell. Biol. 22, 1868-1880 (Pubitemid 34175002)
25. Lehman, N. L., Verschuren, E. W., Hsu, J. Y., Cherry, A. M., and Jackson, P. K. (2006) Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 5, 1569-1573 (Pubitemid 44091978)
26. Wohlschlegel, J. A., Dwyer, B. T., Dhar, S. K., Cvetic, C., Walter, J. C., and Dutta, A. (2000) Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 290, 2309-2312 (Pubitemid 32041574)
27. Tada, S., Li, A., Maiorano, D., Méchali, M., and Blow, J. J. (2001) Repression of origin assembly in metaphase depends on inhibition of RLF-B/ Cdt1 by geminin. Nat. Cell Biol. 3, 107-113 (Pubitemid 32118362)
28. Listovsky, T., Oren, Y. S., Yudkovsky, Y., Mahbubani, H. M., Weiss, A. M., Lebendiker, M., and Brandeis, M. (2004) Mammalian Cdh1/Fzr mediates its own degradation. EMBO J. 23, 1619-1626 (Pubitemid 38579522)
29. Rape, M., and Kirschner, M. W. (2004) Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 432, 588-595 (Pubitemid 39626259)
30. Melixetian, M., Ballabeni, A., Masiero, L., Gasparini, P., Zamponi, R., Bartek, J., Lukas, J., and Helin, K. (2004) Loss of Geminin induces rereplication in the presence of functional p53. J. Cell Biol. 165, 473-482 (Pubitemid 38679613)
31. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., and Bonner, W. M. (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (Pubitemid 28124064)
32. Stiff, T., Walker, S. A., Cerosaletti, K., Goodarzi, A. A., Petermann, E., Concannon, P., O'Driscoll, M., and Jeggo, P. A. (2006) ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25, 5775-5782 (Pubitemid 44967761)
33. Terashima, T., and Tolmach, L. J. (1963) X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 140, 490-492
34. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52, 3495-3497
35. Milas, L., Hunter, N. R., Mason, K. A., Kurdoglu, B., and Peters, L. J. (1994) Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res. 54, 3506-3510 (Pubitemid 24225974)
36. Zhang, A. L., Russell, P. J., Knittel, T., and Milross, C. (2007) Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Prostate 67, 1630-1640 (Pubitemid 350036949)
37. Guan, Z., Wang, X. R., Zhu, X. F., Huang, X. F., Xu, J., Wang, L. H., Wan, X. B., Long, Z. J., Liu, J. N., Feng, G. K., Huang, W., Zeng, Y. X., Chen, F. J., and Liu, Q. (2007) Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res. 67, 10436-10444 (Pubitemid 350070819)
38. Tao, Y., Zhang, P., Frascogna, V., Lecluse, Y., Auperin, A., Bourhis, J., and Deutsch, E. (2007) Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br. J. Cancer 97, 1664-1672 (Pubitemid 350249356)
39. Moretti, L., Niermann, K., Schleicher, S., Giacalone, N. J., Varki, V., Kim, K. W., Kopsombut, P., Jung, D. K., and Lu, B. (2011) MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation. Int. J. Radiat. Oncol. Biol. Phys. 80, 1189-1197
40. Niermann, K. J., Moretti, L., Giacalone, N. J., Sun, Y., Schleicher, S. M., Kopsombut, P., Mitchell, L. R., Kim, K. W., and Lu, B. (2011) Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition. Radiation Res. 175, 444-451
41. Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, CS, Murray, S. F., Gaus, H., Seth, P. P., Swayze, E. E., and Crooke, S. T. (2012) Single-stranded siRNAs activate RNAi in animals. Cell 150, 883-894
42. Yu, D., Pendergraff, H., Liu, J., Kordasiewicz, H. B., Cleveland, D. W., Swayze, E. E., Lima, W. F., Crooke, S. T., Prakash, T. P., and Corey, D. R. (2012) Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant Huntingtin expression. Cell 150, 895-908
43. Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., and Gress, T. M. (2005) Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24, 6626-6636 (Pubitemid 41486793)
44. Dyrskjøt, L., Kruhøffer, M., Thykjaer, T., Marcussen, N., Jensen, J. L., Møller, K., and Ørntoft, T. F. (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 64, 4040-4048
45. French, P. J., Swagemakers, S. M., Nagel, J. H., Kouwenhoven, M. C., Brouwer, E., van der Spek, P., Luider, T. M., Kros, J. M., van den Bent, M. J., and Sillevis Smitt, P. A. (2005) Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res. 65, 11335-11344 (Pubitemid 41821690)
46. Ginos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., and Gaffney, P. M. (2004) Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 64, 55-63 (Pubitemid 38114082)
47. Korkola, J. E., Houldsworth, J., Chadalavada, R. S., Olshen, A. B., Dobrzynski, D., Reuter, V. E., Bosl, G. J., and Chaganti, R. S. (2006) Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66, 820-827 (Pubitemid 43165947)
48. Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M., Kelsey, K. T., Turek, L. P., and Ahlquist, P. (2007) Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67, 4605-4619 (Pubitemid 46910165)
49. Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132 (Pubitemid 43202662)
50. Sun, L., Hui, A. M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., Walling, J., Bailey, R., Rosenblum, M., Mikkelsen, T., and Fine, H. A. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9, 287-300 Technology Technology Technology Technology Technology Technology